LGT Group Foundation Buys 23,965 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

LGT Group Foundation boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 289,568 shares of the company’s stock after acquiring an additional 23,965 shares during the period. LGT Group Foundation owned 0.23% of Henry Schein worth $20,038,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Clarkston Capital Partners LLC increased its stake in Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after acquiring an additional 71,560 shares during the period. Nuance Investments LLC increased its stake in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after acquiring an additional 414,748 shares during the period. Olstein Capital Management L.P. increased its stake in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Henry Schein during the 3rd quarter worth $515,000. Finally, Equitable Trust Co. bought a new position in shares of Henry Schein in the 4th quarter valued at $417,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.1 %

Shares of HSIC opened at $72.17 on Monday. The company has a market capitalization of $9.00 billion, a PE ratio of 29.70, a PEG ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock’s 50-day moving average price is $74.39 and its two-hundred day moving average price is $72.50. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the firm earned $0.66 earnings per share. The business’s quarterly revenue was up 5.8% on a year-over-year basis. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Barrington Research reiterated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group decreased their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Jefferies Financial Group lifted their price target on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target on the stock. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.